申请人:Ribon Therapeutics Inc.
公开号:US20190330194A1
公开(公告)日:2019-10-31
The present invention relates to pyridazinones and related compounds which are inhibitors of PARP7 and are useful in the treatment of cancer.
本发明涉及
吡啶并嗪酮和相关化合物,它们是PARP7的
抑制剂,并且在癌症治疗中很有用。